Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H12N2O3 |
| Molecular Weight | 208.2139 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C=CCC1(CC=C)C(=O)NC(=O)NC1=O
InChI
InChIKey=FDQGNLOWMMVRQL-UHFFFAOYSA-N
InChI=1S/C10H12N2O3/c1-3-5-10(6-4-2)7(13)11-9(15)12-8(10)14/h3-4H,1-2,5-6H2,(H2,11,12,13,14,15)
| Molecular Formula | C10H12N2O3 |
| Molecular Weight | 208.2139 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Allobarbital (5,5-diallylbarbituric acid) is a medium to long-acting barbiturate. It is under international control according to the UN Convention on Psychotropic Substances (Schedule IV). It is used as a sedative and hypnotic and in combination with acetaminophen and codeine as an analgesic. Allobarbital exerts anticonvulsive activity through GABA-ergic mechanisms. Sulfuric derivatives of allobarbital may exert anti-inflammatory activity.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Rostral ventrolateral medullary but not medullary lateral tegmental field neurons mediate sympatho-sympathetic reflexes in cats. | 2010-11 |
|
| [Studies on the structure-activity relationship of allyl substituted oxopyrimidines searching for the novel antagonist or agonist of barbiturates to the sleep mechanism based on the uridine receptor theory--barbituric acid to uridine (part I)]. | 2005-01 |
|
| Application of atmospheric pressure chemical ionisation mass spectrometry in the analysis of barbiturates by high-speed analytical countercurrent chromatography. | 2003 |
|
| Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001-11 |
|
| The hepatic extraction of plasma free amino acids and response to hepatic portal venous infusion of methionine sources in anesthetized SCWL males (Gallus domesticus). | 2001-09 |
|
| Improved solid-phase extraction method for systematic toxicological analysis in biological fluids. | 2001-03 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:02 GMT 2025
by
admin
on
Mon Mar 31 17:50:02 GMT 2025
|
| Record UNII |
8NT43GG2HA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
N05CA21
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
||
|
NCI_THESAURUS |
C67084
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
||
|
WHO-VATC |
QN05CA21
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m1525
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
516
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | RxNorm | ||
|
5842
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
200-140-4
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
SUB05334MIG
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
8NT43GG2HA
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
CHEMBL267719
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
DTXSID9022572
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
ALLOBARBITAL
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
100000092760
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
2266
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
9324
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
52-43-7
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
C084828
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
C76522
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
Allobarbital
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
122
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY | |||
|
DB13577
Created by
admin on Mon Mar 31 17:50:02 GMT 2025 , Edited by admin on Mon Mar 31 17:50:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|